EGFR and cancer: The activation of EGFR is prevalent in cancer signaling and not only activates PI3K by recruiting the regulatory subunit, p85 [13], but also induces activation of the mitogen-activated protein kinase (MAPK) pathway by either Grb2 or Shc adaptor proteins [14].